Mesenchymal stem cell application and its therapeutic mechanisms in intracerebral hemorrhage
Intracerebral hemorrhage (ICH), a common lethal subtype of stroke accounting for nearly 10-15% of the total stroke disease and affecting two million people worldwide, has a high mortality and disability rate and, thus, a major socioeconomic burden. However, there is no effective treatment available...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
13 June 2022
|
| In: |
Frontiers in cellular neuroscience
Year: 2022, Volume: 16, Pages: 1-16 |
| ISSN: | 1662-5102 |
| DOI: | 10.3389/fncel.2022.898497 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.3389/fncel.2022.898497 Verlag, lizenzpflichtig, Volltext: https://www.frontiersin.org/articles/10.3389/fncel.2022.898497 
|
| Author Notes: | Guoqiang Yang, Xuehui Fan, Maryam Mazhar, Sijin Yang, Houping Xu, Nathupakorn Dechsupa and Li Wang |
| Summary: | Intracerebral hemorrhage (ICH), a common lethal subtype of stroke accounting for nearly 10-15% of the total stroke disease and affecting two million people worldwide, has a high mortality and disability rate and, thus, a major socioeconomic burden. However, there is no effective treatment available currently. The role of mesenchymal stem cells (MSCs) in regenerative medicine is well known owing to the simplicity of acquisition from various sources, low immunogenicity, adaptation to the autogenic and allogeneic systems, immunomodulation, self-recovery by secreting extracellular vesicles (EVs), regenerative repair, and antioxidative stress. MSC therapy provides an increasingly attractive therapeutic approach for ICH. Recently, the functions of MSCs such as neuroprotection, anti-inflammation, and improvement in synaptic plasticity have been widely researched in human and rodent models of ICH. MSC transplantation has been proven to improve ICH-induced injury, including the damage of nerve cells and oligodendrocytes, the activation of microglia and astrocytes, and the destruction of blood vessels. The improvement and recovery of neurological functions in rodent ICH models were demonstrated via the mechanisms such as neurogenesis, angiogenesis, anti-inflammation, anti-apoptosis, and synaptic plasticity. Here, we discuss the pathological mechanisms following ICH and the therapeutic mechanisms of MSC-based therapy to unravel new cues for future therapeutic strategies. Furthermore, some potential strategies for enhancing the therapeutic function of MSC transplantation have also been suggested. |
|---|---|
| Item Description: | Gesehen am 12.02.2024 |
| Physical Description: | Online Resource |
| ISSN: | 1662-5102 |
| DOI: | 10.3389/fncel.2022.898497 |